SAN DIEGO--(BUSINESS WIRE)--Neuropore Therapies, Inc., a biopharmaceutical company discovering and developing novel therapeutics for the treatment of Parkinson’s disease, Alzheimer’s disease and other ...
SAN DIEGO & BRUSSELS--Neuropore Therapies Inc. and UCB announced today that they have entered into a world-wide collaboration and agreement to develop and commercialize therapeutic products aiming at ...
SAN DIEGO--(BUSINESS WIRE)--Neuropore Therapies, Inc. announced today that it has commenced Phase 1 clinical trials with NPT200-11, a novel potential treatment for Parkinson’s Disease. “We are pleased ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results